Table 1 Clinicopathological characteristics of patientsamples and expression of PTOV1 in breast cancer
Variables | Number of cases (%) |
|---|---|
Gender | |
Male | 0 (0.0) |
Female | 169 (100.0) |
Age (years) | |
≥ 47 | 89 (52.7) |
< 47 | 80 (47.3) |
Clinical stage | |
I | 30 (17.8) |
II | 81 (47.9) |
III | 53 (31.4) |
IV | 5 (3.0) |
T classification | |
T1 | 52 (30.8) |
T2 | 88 (52.1) |
T3 | 17 (10.1) |
T4 | 12 (7.1) |
N classification | |
N0 | 72 (42.6) |
N1 | 50 (29.6) |
N2 | 30 (17.8) |
N3 | 17 (10.1) |
M classification | |
No | 164 (97) |
Yes | 5 (3) |
Vital status (at follow-up) | |
alive | 131 (77.5) |
Dead | 38 (22.5) |
Expression of PTOV1 | |
Low expression | 86 (50.9) |
High expression | 83 (49.1) |
Detectable | 167 (99.4) |
Undetectable | 2 (0.6) |
Expression of ER | |
0 | 74 (43.8) |
1 | 37 (21.9) |
2 | 16 (9.5) |
3 | 42 (24.9) |
Expression of PR | |
0 | 75 (44.4) |
1 | 28 (16.6) |
2 | 27 (16.0) |
3 | 39 (23.1) |
Expression of c-erbB2 | |
0 | 90 (53.3) |
1 | 20 (11.8) |
2 | 13 (7.7) |
3 | 46 (27.2) |